Rick Gordon Named Halo Labs CEO – Proven 20 Year Track Record

Rick Gordon has been named Chief Executive Officer. He will assume day-to-day leadership of the Company and will also serve as a member of the Board of Directors.

Rick Gordon has 20 years of experience in the life science tools market and has held senior positions at ForteBio, Phasefocus, and Unchained Labs. Most recently, he served as the Vice President of Global Sales for Halo labs where he oversaw both sales and customer support. He lead the commercial launch of their popular Horizon® and Aura™ instruments, built a global sales and distribution network, and expanded Halo Labs’ customer base to include virtually every major global biopharmaceutical company.

“Rick has a proven track record and is the right leader for Halo Labs,” said Dr. Joe Keegan, Executive Chairman of Halo Labs. “He understands our customers and with Rick’s strategic vision, the company is in a great position to execute on the market opportunities ahead.”

Halo Labs is one of the most innovative companies in our industry and I’m excited about our future,” said Rick Gordon. “Thanks to the efforts of our team, our products have reduced therapeutic development timelines and have revolutionized stability testing across the industry. The Horizon and Aura systems have become the standard for high-throughput, low-volume particle analysis, and they are now considered the technology of choice in cell and gene therapy.”

 

SourceHalo Labs

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.